It is important to remain cautious when interpreting results from ACT studies and extending them to immunocompetent tumor-bearing hosts, as the adoptively transferred CD4+ T cells in these studies were observed to mediate their antitumor effects under lymphopenic conditions. The gene discussed is CD4; the disease is neoplasm.